Micro- and nanoparticle-based vaccines for hepatitis B.

Area of Science:

• Biomaterials Science
• Vaccinology
• Nanotechnology

Background:

• Vaccines are crucial public health tools, but cost and multi-dose requirements hinder global reach.
• Subunit vaccine delivery faces challenges, necessitating innovative approaches.
• Biodegradable polymers offer a promising platform for advanced vaccine delivery systems.

Purpose of the Study:

• To explore the use of biodegradable polymers for enhanced vaccine delivery.
• To investigate poly (lactide-co-glycolide acid) (PLGA) nanoparticles for antigen encapsulation.
• To evaluate the potential of PLGA micro- and nanoparticles for inducing humoral and cellular immune responses.

Main Methods:

• Development of nano/microparticles using biodegradable and biocompatible polymers.
• Encapsulation of vaccine antigens, specifically hepatitis B surface antigen, within PLGA.
• Assessment of polymer properties including safety, biocompatibility, controlled antigen release, and degradation rate.

Main Results:

• PLGA demonstrates favorable properties for vaccine antigen encapsulation and controlled release.
• Micro- and nanoparticles offer potential for improved vaccine delivery compared to conventional methods.
• The use of PLGA aims to induce both humoral and cellular immune responses.

Conclusions:

• PLGA-based nano/microparticles represent a viable strategy to overcome cost and delivery limitations in global vaccination.
• These systems hold promise for enhancing the efficacy of subunit vaccines like the hepatitis B vaccine.
• Further research into PLGA delivery systems can significantly contribute to public health initiatives.